Figure 1From: Cytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatinTreatment Schema. Schematic of 28-day cycle for the administration of GM-CSF, rIFN-γ1b, and carboplatin.Back to article page